BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rocha GR, Lemos FFB, Silva LGO, Luz MS, Correa Santos GL, Rocha Pinheiro SL, Calmon MS, de Melo FF. Overcoming antibiotic-resistant Helicobacter pylori infection: Current challenges and emerging approaches. World J Gastroenterol 2025; 31(10): 102289 [PMID: 40093672 DOI: 10.3748/wjg.v31.i10.102289]
URL: https://www.wjgnet.com/1007-9327/full/v31/i10/102289.htm
Number Citing Articles
1
Ayman Elbehiry, Eman Marzouk, Adil Abalkhail. Unraveling Helicobacter pylori: Insights into Pathogenesis, Immune Evasion, and Progress Toward Effective VaccinationVaccines 2025; 13(7): 725 doi: 10.3390/vaccines13070725
2
Oluwakemi Opeyemi Akinpelu, Humphrey Sam Samuel, David Akpanke Undie, Francis Arinze Ibekwe, Onimisi Princewill Onotu, Emmanuel Edet Etim. Current concepts of Helicobacter pylori infectionEuropean Journal of Medical Research 2025;  doi: 10.1186/s40001-025-03725-7
3
Taly Issa, Pierre Zalloua, Iyad A Issa. Resistance reversal: Taiwan’s <i>Helicobacter pylori</i> trends defy global normsWorld Journal of Gastroenterology 2025; 31(47): 114789 doi: 10.3748/wjg.v31.i47.114789
4
Tehsin Ullah Khan, Mohamed Sharaf, Sohaib Khan, Khurshid Ahmad, Chen-Guang Liu. Advanced nano-delivery systems in H. pylori eradication: targeting, efficacy, and clinical translation Expert Opinion on Drug Delivery 2026; 23(1): 61 doi: 10.1080/17425247.2025.2569642
5
Surbhi Dumra, Abhishek Ray. Recent advances in Helicobacter pylori diagnosis, treatment, and management: a comprehensive reviewExploration of Digestive Diseases 2025; 4 doi: 10.37349/edd.2025.100598
6
Koji Otani, Wang Ying Lai, Jyh‐Ming Liou, Yasuhiro Fujiwara. Antibiotic Resistance in Helicobacter pylori in the Asia‐Pacific Region: A Call for Coordinated Regional StrategiesJournal of Gastroenterology and Hepatology 2025;  doi: 10.1111/jgh.70227
7
Pesila Odera, Geoffrey Otieno, Joab Onyango, Bernhards Ogutu, James Owour, Florence Oloo, Martin Ongas, Hulda Swai, Jeremiah Gathirwa, Arnab Biswas. Nanoformulation and Preclinical Evaluation of Dihydroartemisinin–Lumefantrine and Primaquine as Combined Antimalarial TherapyJournal of Nanotechnology 2025; 2025(1) doi: 10.1155/jnt/5162847
8
Kareem Ibraheem, Osama Hroub, Abdalrahman N. Herbawi, Majed Dwaik. Helicobacter pylori - Diagnosis, Pathogenesis, and Treatment Strategies2025;  doi: 10.5772/intechopen.1010640
9
Vidya Suresh, Amritavarshini Sreekumar, Anil Kumar, Shine Sadasivan, Raja Biswas, Lalitha Biswas. Therapeutic advances and future directions in Helicobacter pylori eradicationFrontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1652943
10
COMPARATIVE EFFICACY OF VONOPRAZAN AND PROTON PUMP INHIBITORS IN HELICOBACTER PYLORI ERADICATION BASED ON CLARITHROMYCIN SUSCEPTIBILITY: A SYSTEMATIC REVIEW AND META-ANALYSISAsian Journal of Pharmaceutical and Clinical Research 2025; : 133 doi: 10.22159/ajpcr.2025v18i9.55714
11
Sourav Pal, Junaid Ahamed Laskar, Biprojit Bhowmick, Khokan Bera. Helicobacter pylori in peptic ulcer disease: pathogenesis, gastric microbiome, and innovative therapiesBulletin of the National Research Centre 2025; 49(1) doi: 10.1186/s42269-025-01346-y
12
Jun-Hyung Cho, So-Young Jin. Diagnosis and treatment of Helicobacter pylori infection: past, present, and future Future Microbiology 2025; 20(13): 913 doi: 10.1080/17460913.2025.2568326
13
Shivani Kunkalienkar, Neha S. Gandhi, Ashutosh Gupta, Moumita Saha, Aravinda Pai, Shiran Shetty, Abhishek Gupta, Namdev Dhas, Raghu Chandrashekar Hariharapura, K. Nandakumar, Nagalakshmi Narasimhaswamy, Sudheer Moorkoth. Targeting Urease: A Promising Adjuvant Strategy for Effective Helicobacter pylori EradicationACS Omega 2025; 10(27): 28643 doi: 10.1021/acsomega.5c02725